On June 10th, during the ceremony at the Chancellery of the Prime Minister of Poland, the CEO of Polpharma Group Markus Sieger signed an agreement
with the Medical Research Agency initiating the Warsaw Health Innovation Hub.This is the first initiative of this type in Central Europe, which will
combine the cooperation of the public sector with business in order to create innovative medical, technological and legal solutions, to improve patients’
health and to increase the efficiency of the Polish health care system.The Warsaw Health Innovation Hub is to help respond to the challenges of public
health such as aging society, outbreaks of infectious and chronic diseases, rising costs compared to limited resources.

As part of this initiative, Polpharma wants to effectively support the needs of Polish patients, building added value for the health care system, especially in terms of increasing drug security and achieving goals in accordance with the Pharmaceutical Strategy for Europe – said Markus Sieger.

Polpharma recognizes the need to ensure a sustainable supply chain and effective and affordable medicines as key issues. Apart from our company, the
agreement was concluded by other partners: Microsoft, AstraZeneca, Roche and EIT Health, which will act as the hub operator.